Securities code: Lbx Pharmacy Chain Joint Stock Company(603883) securities abbreviation: Lbx Pharmacy Chain Joint Stock Company(603883) Announcement No.: 2022014 Lbx Pharmacy Chain Joint Stock Company(603883)
Announcement on changing the implementation location of some raised investment projects
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
● Lbx Pharmacy Chain Joint Stock Company(603883) (hereinafter referred to as “the company” or ” Lbx Pharmacy Chain Joint Stock Company(603883) “) deliberated and adopted the proposal on changing the implementation location of some raised investment projects at the 13th meeting of the 4th board of directors and the 11th meeting of the 4th board of supervisors held on March 6, 2022, It is agreed that the company will change the implementation site of ” Huadong Medicine Co.Ltd(000963) product sorting and processing project” from plot of Jiangning Airport Economic Development Zone, Nanjing, Jiangsu Province to plot 57, Nanyuan, high tech Zone, Yangzhou, Jiangsu Province.
● the change of the implementation location of some raised investment projects will not change the purpose of the raised investment projects, and there will be no disguised change in the purpose of the raised funds and damage the interests of shareholders, which will not have a significant adverse impact on the implementation of the raised investment projects and the normal operation of the company.
1、 Basic information of raised funds
Approved by the reply on approving Lbx Pharmacy Chain Joint Stock Company(603883) non-public Development Bank shares (zjxk [2021] No. 2294) of China Securities Regulatory Commission (hereinafter referred to as the “CSRC”), the company issued RMB common shares (A shares) to specific investors in the form of non-public offering of shares, and the total amount of funds raised was RMB 174045367380, After deducting the issuance expenses excluding tax of RMB 1517976529, the net amount of raised funds is RMB 172527390851. All the above-mentioned raised funds have been in place on January 27, 2022, and have been verified by zhongshenhua Certified Public Accountants (special general partnership) and issued Lbx Pharmacy Chain Joint Stock Company(603883) capital verification report (CAC Zheng Yan Zi [2022] No. 0012). The company has stored the raised funds in a special account in accordance with relevant regulations, and signed a tripartite supervision agreement on the raised funds with the sponsor and the bank storing the raised funds.
2、 Investment projects with raised funds
According to the company’s plan for non-public development of A-share shares, the company’s fund-raising projects and fund-raising use plans are as follows:
Unit: 10000 yuan
Project name project investment total raised fund proposed amount investment amount
1 new chain drugstore project 13440 Dongguan Winnerway Industry Zone Ltd(000573) 2832
2 Huadong Medicine Co.Ltd(000963) product sorting and processing project 31148472788044
3 enterprise digital platform and new retail construction project 3662 Troy Information Technology Co.Ltd(300366) 2300
4 supplementary working capital 52213615221361
Total 2543850817404537
3、 Change of implementation location of some raised investment projects
The raised investment project of the proposed change of implementation location is ” Huadong Medicine Co.Ltd(000963) product sorting and processing project”. In order to speed up the progress of the project and comprehensively consider the factors such as distribution distance, logistics cost and land use certainty, after the full demonstration and analysis of the company’s management, the company plans to change the implementation location of the above raised investment project to plot 57, Nanyuan, high tech Zone, Yangzhou City, Jiangsu Province. The specific changes are as follows:
Implementation place before project name change and implementation place after project name change
Huadong Medicine Co.Ltd(000963) Jiangning airport economy, Nanjing, Jiangsu Province Product sorting Development Zone, No. 57, Nanyuan, high tech Zone, Yangzhou, Jiangsu Province, north of Jiayuan Road, Jingyi block, east of Ji’an South Road, west of Huading electric appliance processing project road, north of Jiayuan North Road, west of Runyang road and south of planned road
The company has signed the entry contract with Yangzhou high tech Industrial Development Zone and formed a framework agreement on land transfer and investment. However, due to the fact that the above land has not completed the “signboard hanging” process and land transfer procedures, there is still some uncertainty. The final area of land and other specific contents shall be subject to the actually obtained land use certificate.
4、 The impact of this change on the implementation location of some raised investment projects
The change of the implementation location of some raised investment projects will not change the purpose of the raised investment projects, there is no situation of changing the purpose of the raised funds in a disguised form and damaging the interests of shareholders, and will not have a significant adverse impact on the implementation of the raised investment projects and the normal operation of the company.
5、 Review procedures and special opinions
(I) deliberations of the board of directors
On March 6, 2022, the company held the 13th meeting of the 4th board of directors, deliberated and approved the proposal on changing the implementation location of some raised investment projects, and agreed to change the implementation location of ” Huadong Medicine Co.Ltd(000963) product sorting and processing project” from plot of Jiangning Airport Economic Development Zone, Nanjing, Jiangsu Province to plot 57, Nanyuan, high tech Zone, Yangzhou, Jiangsu Province.
(II) deliberation of the board of supervisors
On March 6, 2022, the company held the 11th meeting of the 4th board of supervisors, deliberated and approved the proposal on changing the implementation location of some raised investment projects, and agreed to change the implementation location of some raised investment projects. The board of supervisors believes that this matter complies with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, and the guidelines for the self-discipline supervision of listed companies No. 1 – standardized operation of Shanghai Stock Exchange. This change does not change the purpose and investment direction of the raised funds, and there is no situation of changing the investment direction of the raised funds in a disguised form or damaging the interests of shareholders, which is conducive to accelerating the smooth implementation of the investment projects with raised funds and in line with the interests of the company and all shareholders.
(III) opinions of independent directors
The independent directors of the company believe that the change of the implementation location of the raised capital investment project ” Huadong Medicine Co.Ltd(000963) product sorting and processing project” is conducive to the implementation of the company’s business development plan, more effective use of the raised capital, in line with the company’s long-term interests and the use arrangement of the raised capital, and will not affect the normal progress of the raised capital investment project, There is no situation of changing the investment direction of the raised funds in a disguised form and damaging the interests of shareholders.
This change has fulfilled the necessary decision-making procedures and complies with the relevant provisions of laws and regulations such as the stock listing rules of Shanghai Stock Exchange, the articles of association and the self regulatory guidelines for listed companies of Shanghai Stock Exchange No. 1 – standardized operation. The independent directors of the company agree to change the implementation location of the raised capital investment project ” Huadong Medicine Co.Ltd(000963) product sorting and processing project”.
(IV) verification opinions of the recommendation institution
1. Lbx Pharmacy Chain Joint Stock Company(603883) the issue of changing the implementation location of some raised investment projects has been deliberated and approved by the 13th meeting of the 4th board of directors and the 11th meeting of the 4th board of supervisors respectively. The independent directors of the company have issued explicit consent opinions and fulfilled the necessary approval procedures, which are in line with relevant laws, regulations, normative documents and the articles of association The provisions of the measures for the administration of raised funds;
2. The company’s change of the implementation location of some raised investment projects this time will not change the purpose of the raised investment projects, there is no situation of changing the purpose of the raised funds in a disguised manner and damaging the interests of shareholders, and will not have a significant adverse impact on the implementation of the raised investment projects and the normal operation of the company.
In conclusion, the recommendation institution has no objection to Lbx Pharmacy Chain Joint Stock Company(603883) this change of the implementation location of some raised investment projects. It is hereby announced.
Lbx Pharmacy Chain Joint Stock Company(603883) board of directors
March 6, 2022
